Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Bioorg Med Chem Lett. 2013 Nov 23;24(1):195–198. doi: 10.1016/j.bmcl.2013.11.042

Figure 5.

Figure 5

Radioactive HPLC profile of urine sample of a B16/F1 melanoma-bearing C57 mouse at 2 h post-injection of 99mTc-RAD-Arg-(Arg11)CCMSH. The retention time (13.3 min) of the original compound of 99mTc-RAD-Arg-(Arg11)CCMSH prior to the tail vein injection is identical with that of the urine sample of 99mTc-RAD-Arg-(Arg11)CCMSH.